EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Is hyperoxia during veno-arterial extracorporeal life support due to cardiopulmonary failure associated with mortality in pediatric patients?

Asaad G Beshish iD, Rebecca Shamah, Joshua Qian, Kasey Keane-Lerner, Paola Rodriguez Morales, Tawanda Zinyandu, Joel Davis, Joshua M Rosenblum, Heather K Viamonte

The Journal of ExtraCorporeal Technology · 2025

DOI: 10.1051/ject/2025006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of ExtraCorporeal Technology, 2025. Verfasst von Asaad G Beshish und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Cardiology, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA 30329, USA. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Hyperoxia, Heart Failure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Data is limited regarding the effects of supraphysiologic blood oxygen tension in patients requiring extracorporeal life support (ECLS). We sought to evaluate the association between hyperoxia and outcomes in pediatric patients requiring veno-arterial (VA) ECLS.

Methods

Retrospective single-center study at an academic children’s hospital that included all patients 0–18 years who required VA-ECLS between 01/2014 and 12/2019.

Results

During the study period, 229 VA-ECLS runs occurred in 229 patients. The majority of patients were neonates (73.4%), with cardiac being the most common indication (48.9%). The median time from admission to cannulation was 78.5 h (IQR 14, 356) with a median ECLS duration of 111.5 h (IQR 65.5, 184.5). The overall mortality rate was 44.5%. Using a receiver operating curve, a mean PaO 2 of 233 mmHg in the first 48 h of ECLS was determined to have the optimal discriminatory ability for mortality (sensitivity 36% and specificity 76%). Of the VA-ECLS cohort, 68 (29.7%) had a mean PaO 2 > 233 mmHg (hyperoxia group). The hyperoxia group tended to be older (median age 4.6 vs 1.5 months, p = 0.019), had a primary cardiac indication for VA-ECLS (60% vs 44%, p = 0.0004), and had a higher mortality rate (54% vs 40%, p = 0.050). In the multivariable analysis, after adjusting for covariables, the data demonstrated increased odds of mortality (aOR 2.02, 95% CI [1.03, 3.97], p = 0.03). The odds of development of stage II or III acute kidney injury (AKI) (aOR 2.04, 95% CI [0.82, 5.50]), but that did not reach statistical significance ( p = 0.120).

Conclusion

There is evidence that hyperoxia during the first 48 h of VA-ECLS may be associated with mortality and development of acute kidney injury, although this did not reach statistical significance. Multicenter and prospective evaluation of this modifiable risk factor is imperative to improve the care of this high-risk cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationHyperoxiaHeart FailureHumansInfantRetrospective StudiesChildFemaleMaleChild, PreschoolInfant, NewbornAdolescent

Stichwörter der Autor:innen

Extracorporeal Life Support (ECLS)Functional Status Scale (FSS)HyperoxiaMortalityVeno-arterial Extracorporeal Life Support (VA-ECLS)

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Cardiology, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA 30329, USA.
  • Emory University School of Medicine, Atlanta, GA 30329, USA.
  • Physician Assistant, Children's Healthcare of Atlanta, Atlanta, GA 30329, USA.
  • Senior Research Coordinator, Children's Healthcare of Atlanta, Atlanta, GA 30329, USA.
  • Advanced Technology Coordinator, ECMO and Advanced Technologies, Children's Healthcare of Atlanta, Atlanta, GA 30329, USA.
  • Department of Surgery, Division of Cardiothoracic Surgery, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA 30329, USA.

ORCID-Profile: Asaad G Beshish

Zitieren

APA

Beshish, A. G., Shamah, R., Qian, J., Keane-Lerner, K., Morales, P. R., Zinyandu, T., Davis, J., Rosenblum, J. M., & Viamonte, H. K. (2025). Is hyperoxia during veno-arterial extracorporeal life support due to cardiopulmonary failure associated with mortality in pediatric patients?. The Journal of ExtraCorporeal Technology. https://doi.org/10.1051/ject/2025006

Vancouver

Beshish AG, Shamah R, Qian J, Keane-Lerner K, Morales PR, Zinyandu T, et al. Is hyperoxia during veno-arterial extracorporeal life support due to cardiopulmonary failure associated with mortality in pediatric patients?. The Journal of ExtraCorporeal Technology. 2025. doi:10.1051/ject/2025006

BibTeX
@article{Beshish2025,
  author = {Beshish, Asaad G and Shamah, Rebecca and Qian, Joshua and Keane-Lerner, Kasey and Morales, Paola Rodriguez and Zinyandu, Tawanda and Davis, Joel and Rosenblum, Joshua M and Viamonte, Heather K},
  title = {Is hyperoxia during veno-arterial extracorporeal life support due to cardiopulmonary failure associated with mortality in pediatric patients?},
  journal = {The Journal of ExtraCorporeal Technology},
  year = {2025},
  doi = {10.1051/ject/2025006}
}
Kostenlos starten →